Moxidectin induces autophagy arrest in colorectal cancer
Colorectal cancer (CRC) is a cancer with a high morbidity and mortality worldwide. Hence, developing new therapeutic drugs for CRC is very important. Moxidectin (MOX) has shown good anti-glioblastoma effect both in vitro and in vivo. This study aimed to elucidate the anti-CRC effect of MOX and its p...
Gespeichert in:
| Veröffentlicht in: | Medical oncology (Northwood, London, England) London, England), 2022-09, Vol.39 (12), p.211-211, Article 211 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 211 |
|---|---|
| container_issue | 12 |
| container_start_page | 211 |
| container_title | Medical oncology (Northwood, London, England) |
| container_volume | 39 |
| creator | Mao, Yushan Xie, Hanhan Shu, Dan Cheng, Lin Lan, Jingbin Pan, Kejian |
| description | Colorectal cancer (CRC) is a cancer with a high morbidity and mortality worldwide. Hence, developing new therapeutic drugs for CRC is very important. Moxidectin (MOX) has shown good anti-glioblastoma effect both in vitro and in vivo. This study aimed to elucidate the anti-CRC effect of MOX and its potential mechanism by investigating the influence of MOX on the viability, apoptosis, necrosis and autophagy of colorectal cancer cells (HCT15 and SW620) and its underlying mechanisms. It was found that MOX can induce autophagy arrest, promote autophagy initiation, inhibit autophagic flux and cell proliferation, simultaneously PI3K-Akt-mTOR signaling pathway and microtubule acetylation. Furthermore, MOX suppressed the growth of xenograft tumors, which was consistent with the in vitro results. |
| doi_str_mv | 10.1007/s12032-022-01799-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2720426573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2719245125</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-7c8102f37d74cb523d0988794b0d71394db314f95c518b61210e315835092dab3</originalsourceid><addsrcrecordid>eNp9kE9LxDAQxYMouK5-AU8FL16qM5Nm0xxl8R-seFHwFtI0Xbt0mzVpQb-9WVdQPHgYZmB-7_F4jJ0iXCCAvIxIwCkHSoNSqVzssQkKoXLk-LL_6z5kRzGuAAgFqQkrH_x7Wzs7tH3W9vVoXczMOPjNq1l-ZCYEF4f0yKzvfEiY6TJreuvCMTtoTBfdyfeesueb66f5Xb54vL2fXy1yy4EPubQlAjVc1rKwlSBegypLqYoKaolcFXXFsWiUsALLaoaE4DiKkgtQVJuKT9n5zncT_NuY0uh1G63rOtM7P0ZNkqCgmZA8oWd_0JUfQ5_SJQoVFQJJJIp2lA0-xuAavQnt2oQPjaC3ZepdmTqVqb_K1FsR34ligvulCz_W_6g-AbqLdPo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2719245125</pqid></control><display><type>article</type><title>Moxidectin induces autophagy arrest in colorectal cancer</title><source>SpringerLink Journals</source><creator>Mao, Yushan ; Xie, Hanhan ; Shu, Dan ; Cheng, Lin ; Lan, Jingbin ; Pan, Kejian</creator><creatorcontrib>Mao, Yushan ; Xie, Hanhan ; Shu, Dan ; Cheng, Lin ; Lan, Jingbin ; Pan, Kejian</creatorcontrib><description>Colorectal cancer (CRC) is a cancer with a high morbidity and mortality worldwide. Hence, developing new therapeutic drugs for CRC is very important. Moxidectin (MOX) has shown good anti-glioblastoma effect both in vitro and in vivo. This study aimed to elucidate the anti-CRC effect of MOX and its potential mechanism by investigating the influence of MOX on the viability, apoptosis, necrosis and autophagy of colorectal cancer cells (HCT15 and SW620) and its underlying mechanisms. It was found that MOX can induce autophagy arrest, promote autophagy initiation, inhibit autophagic flux and cell proliferation, simultaneously PI3K-Akt-mTOR signaling pathway and microtubule acetylation. Furthermore, MOX suppressed the growth of xenograft tumors, which was consistent with the in vitro results.</description><identifier>ISSN: 1559-131X</identifier><identifier>ISSN: 1357-0560</identifier><identifier>EISSN: 1559-131X</identifier><identifier>DOI: 10.1007/s12032-022-01799-5</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Apoptosis ; Autophagy ; Cancer therapies ; Cell growth ; Colorectal cancer ; Dehydrogenases ; Drugs ; Flow cytometry ; Hematology ; Internal Medicine ; Medical research ; Medical schools ; Medicine ; Medicine & Public Health ; Oncology ; Original Paper ; Pathology</subject><ispartof>Medical oncology (Northwood, London, England), 2022-09, Vol.39 (12), p.211-211, Article 211</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c303t-7c8102f37d74cb523d0988794b0d71394db314f95c518b61210e315835092dab3</cites><orcidid>0000-0002-9172-157X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12032-022-01799-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12032-022-01799-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Mao, Yushan</creatorcontrib><creatorcontrib>Xie, Hanhan</creatorcontrib><creatorcontrib>Shu, Dan</creatorcontrib><creatorcontrib>Cheng, Lin</creatorcontrib><creatorcontrib>Lan, Jingbin</creatorcontrib><creatorcontrib>Pan, Kejian</creatorcontrib><title>Moxidectin induces autophagy arrest in colorectal cancer</title><title>Medical oncology (Northwood, London, England)</title><addtitle>Med Oncol</addtitle><description>Colorectal cancer (CRC) is a cancer with a high morbidity and mortality worldwide. Hence, developing new therapeutic drugs for CRC is very important. Moxidectin (MOX) has shown good anti-glioblastoma effect both in vitro and in vivo. This study aimed to elucidate the anti-CRC effect of MOX and its potential mechanism by investigating the influence of MOX on the viability, apoptosis, necrosis and autophagy of colorectal cancer cells (HCT15 and SW620) and its underlying mechanisms. It was found that MOX can induce autophagy arrest, promote autophagy initiation, inhibit autophagic flux and cell proliferation, simultaneously PI3K-Akt-mTOR signaling pathway and microtubule acetylation. Furthermore, MOX suppressed the growth of xenograft tumors, which was consistent with the in vitro results.</description><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Cancer therapies</subject><subject>Cell growth</subject><subject>Colorectal cancer</subject><subject>Dehydrogenases</subject><subject>Drugs</subject><subject>Flow cytometry</subject><subject>Hematology</subject><subject>Internal Medicine</subject><subject>Medical research</subject><subject>Medical schools</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Original Paper</subject><subject>Pathology</subject><issn>1559-131X</issn><issn>1357-0560</issn><issn>1559-131X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kE9LxDAQxYMouK5-AU8FL16qM5Nm0xxl8R-seFHwFtI0Xbt0mzVpQb-9WVdQPHgYZmB-7_F4jJ0iXCCAvIxIwCkHSoNSqVzssQkKoXLk-LL_6z5kRzGuAAgFqQkrH_x7Wzs7tH3W9vVoXczMOPjNq1l-ZCYEF4f0yKzvfEiY6TJreuvCMTtoTBfdyfeesueb66f5Xb54vL2fXy1yy4EPubQlAjVc1rKwlSBegypLqYoKaolcFXXFsWiUsALLaoaE4DiKkgtQVJuKT9n5zncT_NuY0uh1G63rOtM7P0ZNkqCgmZA8oWd_0JUfQ5_SJQoVFQJJJIp2lA0-xuAavQnt2oQPjaC3ZepdmTqVqb_K1FsR34ligvulCz_W_6g-AbqLdPo</recordid><startdate>20220929</startdate><enddate>20220929</enddate><creator>Mao, Yushan</creator><creator>Xie, Hanhan</creator><creator>Shu, Dan</creator><creator>Cheng, Lin</creator><creator>Lan, Jingbin</creator><creator>Pan, Kejian</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9172-157X</orcidid></search><sort><creationdate>20220929</creationdate><title>Moxidectin induces autophagy arrest in colorectal cancer</title><author>Mao, Yushan ; Xie, Hanhan ; Shu, Dan ; Cheng, Lin ; Lan, Jingbin ; Pan, Kejian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-7c8102f37d74cb523d0988794b0d71394db314f95c518b61210e315835092dab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Cancer therapies</topic><topic>Cell growth</topic><topic>Colorectal cancer</topic><topic>Dehydrogenases</topic><topic>Drugs</topic><topic>Flow cytometry</topic><topic>Hematology</topic><topic>Internal Medicine</topic><topic>Medical research</topic><topic>Medical schools</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Original Paper</topic><topic>Pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mao, Yushan</creatorcontrib><creatorcontrib>Xie, Hanhan</creatorcontrib><creatorcontrib>Shu, Dan</creatorcontrib><creatorcontrib>Cheng, Lin</creatorcontrib><creatorcontrib>Lan, Jingbin</creatorcontrib><creatorcontrib>Pan, Kejian</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Medical oncology (Northwood, London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mao, Yushan</au><au>Xie, Hanhan</au><au>Shu, Dan</au><au>Cheng, Lin</au><au>Lan, Jingbin</au><au>Pan, Kejian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Moxidectin induces autophagy arrest in colorectal cancer</atitle><jtitle>Medical oncology (Northwood, London, England)</jtitle><stitle>Med Oncol</stitle><date>2022-09-29</date><risdate>2022</risdate><volume>39</volume><issue>12</issue><spage>211</spage><epage>211</epage><pages>211-211</pages><artnum>211</artnum><issn>1559-131X</issn><issn>1357-0560</issn><eissn>1559-131X</eissn><abstract>Colorectal cancer (CRC) is a cancer with a high morbidity and mortality worldwide. Hence, developing new therapeutic drugs for CRC is very important. Moxidectin (MOX) has shown good anti-glioblastoma effect both in vitro and in vivo. This study aimed to elucidate the anti-CRC effect of MOX and its potential mechanism by investigating the influence of MOX on the viability, apoptosis, necrosis and autophagy of colorectal cancer cells (HCT15 and SW620) and its underlying mechanisms. It was found that MOX can induce autophagy arrest, promote autophagy initiation, inhibit autophagic flux and cell proliferation, simultaneously PI3K-Akt-mTOR signaling pathway and microtubule acetylation. Furthermore, MOX suppressed the growth of xenograft tumors, which was consistent with the in vitro results.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s12032-022-01799-5</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-9172-157X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1559-131X |
| ispartof | Medical oncology (Northwood, London, England), 2022-09, Vol.39 (12), p.211-211, Article 211 |
| issn | 1559-131X 1357-0560 1559-131X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2720426573 |
| source | SpringerLink Journals |
| subjects | Apoptosis Autophagy Cancer therapies Cell growth Colorectal cancer Dehydrogenases Drugs Flow cytometry Hematology Internal Medicine Medical research Medical schools Medicine Medicine & Public Health Oncology Original Paper Pathology |
| title | Moxidectin induces autophagy arrest in colorectal cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A34%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Moxidectin%20induces%20autophagy%20arrest%20in%20colorectal%20cancer&rft.jtitle=Medical%20oncology%20(Northwood,%20London,%20England)&rft.au=Mao,%20Yushan&rft.date=2022-09-29&rft.volume=39&rft.issue=12&rft.spage=211&rft.epage=211&rft.pages=211-211&rft.artnum=211&rft.issn=1559-131X&rft.eissn=1559-131X&rft_id=info:doi/10.1007/s12032-022-01799-5&rft_dat=%3Cproquest_cross%3E2719245125%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2719245125&rft_id=info:pmid/&rfr_iscdi=true |